We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drafts Guidance for Inhaled Nicotine-Containing Drugs
FDA Drafts Guidance for Inhaled Nicotine-Containing Drugs
The FDA unveiled new draft guidance on nonclinical testing of orally-inhaled drug products that contain nicotine — and Commissioner Scott Gottlieb said the agency plans to release follow-up guidelines later this year on potentially clinically relevant outcomes.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor